These findings indicate that, although severe uveitis may be associated with functional defects in cellular immunity in certain cases, in general the measurement of immune responsiveness of peripheral blood lymphocytes is unlikely to aid in the diagnosis or management of chronic posterior uveitis.
Chronic posterior uveitis is an inflammatory disease of unknown origin which may lead to serious visual impairment.! It may present in the context of other inflammatory diseases such as sarcoidosis and vasculitic syndromes and this has led to the suggestion that an impaired or abnormal immune responsive ness may contribute to the pathology of the disease. Further evidence for the involvement of the immune system comes from the finding that a similar form of uveitis can be induced in laboratory animals by the injection of a solu ble antigen isolated from retina-the retinal S-antigen.2,3 It is suggested that an immune response to retinal S-antigen initiates an inflammatory reaction which some individuals are unable to curtail. Support for this sugges tion is provided by the fact that cortico steroids, which are known to suppress the immune system, are effective in the treatment of posterior uveitis and recent reports suggest that Cyclosporin A, which inhibits the activity of T-helper lymphocytes, is also effective. 4 Several studies have indicated that uveitis patients demonstrate abnormalities of the immune system generally.s.6.7.s In addition more recent reports have described altered cellular immune reactivity to retinal S-antigen in patients with a range of ophthalmic dis eases9• 1 0 while elevated levels of antibodies to retinal S-antigen have been demonstrated in uveitis patients, 11.1 2 particularly those with ret inal vasculitis. 1 3 However, some of these studies have failed to note that a significnat proportion of normal individuals also appear to be sensitised to S-antigen.l4.ls We have therefore undertaken an investigation of patients with chronic posterior uveitis in order to determine: (1) Whether there are any differences in lym phocyte subpopulations or cell-mediated immune function in patients that may be related to their eye disease; (2) Whether the immune system of uveitis patients is affected by associated disease e.g. sarcoid or toxoplasmosis;
(3) Whether patients with chronic posterior uveitis are sensitised specifically to retinal S-antigen. Cell mediated immune function was assessed by measuring the response of lym phocytes to non-specific stimulation with T-cell mitogens PHA and Concanavalin A, or specific stimulation with three different antigens: (a) Streptokinase-streptodornase (SK-SD):
an antigen associated with organisms normally present in the gut flora, and to which most of the population is naturally sensitised; (b) purified protein derivative (PPD) from the tubercle bacillus to which most of the population has been sensitised by immunisation; (c) bovine retinal 'S'-antigen.
Other reports have claimed that the number of circulating T-helper or T-sup pressor cells is abnormal in patients with eye disease. We therefore enumerated peripheral blood lymphocytes using two widely used methods each for T and B cells and staining with specific monoclonal antibodies for T-helper and T-suppressor sUbpopulations.
Sensitisation to S-antigen was investigated in three ways: (a) Levels of antibody to S-antigen in serum were measured; (b) Stimulation of peripheral blood lympho cytes with pokeweed mitogen and exam ination of the supernatant for antibody to S-antigen; (c) Measurement of the proliferation of peripheral blood lymphocytes after incubation with S-antigen.
Materials and Methods

Subjects
Patients with chronic posterior uveitis who were being treated at the uveoretina clinic at Aberdeen Royal Infirmary and who gave informed consent were subjects for this study.
A full laboratory and clinical examination was undertaken and the severity of eye disease classified using criteria previously described:l FCR nodules were identified as discrete small yellow or white patches in the choriocapillaris and sub-pigment epithelial space and were a common finding if carefully sought by slit-lamp fundus biomicroscopy. In addition, they characteristically showed as discrete foci of hypofluorescence in the early stages of a fluorescein angiogram with hyper fluorescence in late films. Similar appearances have been described in sympathetic ophthalmial6 which would be graded as cate gory 2 or 3 under the present classification.
Patients with prolonged posterior uveitis due to presumed ocular toxoplasmosis (POT) or presumed ocular histoplasmosis (POH) were classified separately, since they rarely presented evidence of retinal vasculitis and FCR nodules. However, they charac teristically had large patches of chorioretinal inflammatory disease and active vitreous cel lular infiltration. A total of 14 patients was studied, details of whom are given in Table I .
Apart from two patients (nos 7,12) who were receiving topical steriods, none was receiving systemic treatment at the time of testing.
A group of 14 healthy controls was tested at the same time as the patient group.
Methods Lymphocyte Separation
Mononuclear cells were separated from heparinised whole blood using ficoll-hypa quel? and enriched for lymphocytes by incuba tion on plastic for 1 hour. The non-adherent cells were resuspended in 199 medium con taining 20% of heat-inactivated AB serum. A full blood count and differential white cell count was performed on the same blood sample.
Preparation of S-antigen
S-antigen was prepared from fresh bovine ret inae as previously described. IS It was further purified on a Gilson HPLC gradient system. (Dua, Sewell and Forrester submitted) and eluted as a single peak from the column. The antigen was checked for purity by SDS poly acrylamide gel electrophoresis on the T-lymphocytes were enumerated both by E-rosetting and by indirect immunofluores cence using monoclonal antibody to the CD 3 antigen (UCHT 1, Oxoid). T-helper and sup pressor subsets were enumerated using mono clonal antibodies to the CD4 and' CD8 antigens respectively (leu 3a/b and leu 2a from Becton-Dickinson) as previously described. 19 The E-rosette method was used as pre viously described20 except that slides of the 
Measurement of Antibody to S-antigen
The antibody was measured using an ELISA technique as previously described. 1 5 For each assay a calibration curve was constructed using a standard high activity reference serum. Levels of antibody in the unknown sera were measured at a 1:100 dilution (which for most samples was on the linear part of the sigmoid calibration curve) and the results expressed as a percentage of the optical den sity of the reference serum at a 1: 100 dilution. The levels of antibody in PWM supernatants were measured as follows: Optical density readings of a 50% solution of supernatant were found to fall most consistently on the linear part of the calibration curve.
Results are therefore expressed as the con centration of the reference serum (expressed as a percentage) which gave an equivalent optical density to a 50% solution of PWM supernatant. Readings which were outside the linear part of the curve (equivalent to a 10% solution of reference serum) are expressed as being greater than 10%.
Analysis of Results
The results were analysed on the Honeywell 66/80 computer at Aberdeen University using the "Minitab" statistical package. 21 The data was first examined to compare the overall results of each test for patients and controls. Subsequently the patient data was subdivided on the basis of disease severity, or associated disease. For the purpose of statistical analysis the disease categories 1, 2 and 3, were con sidered together as 'mild' disease and cate gories 4 and 5 were considered as 'severe' disease. Data taken from patients with associ ated sarcoid disease were also analysed as a separate subgroup. Groups were compared using either Students t-test or an analysis of variance as appropriate.
Results
Lymphocyte Transformation
The mean proliferative responses to mitogens and antigens are shown in Table II .
The results for the patients and control groups were similar except for the response to SK-SD. The patient group as a whole was slightly, although not significantly reduced; the reduction was due to a minimal response in the four patients with severe disease (mean cpm: 1477 ± 498 compared with 7318 ± 1476 in the controls (p<O.Ol». Two further patients (nos. 1 and 10, both with tox oplasmosis or presumed ocular tox oplasmosis) had a virtually negative response to PPD and a reduced response to PHA and Con A. Their levels of circulating T-cells how ever were normal.
Lymphocyte Subpopulation
The results for patients and controls are shown in Table III . The mean number of lym phocytes of the patient group was lower than that of the control group due to a reduction in the T-helper cell subset but the differences did not reach statistical significance. Within the patient group only one individual had a level of T-helper cells that could be considered clinically significant (patient no. 8, 0.33 x 106 per ml). This patient's transformation responses were normal, except for PPD which was low. The patient had mild eye disease but had associated sarcoidosis.
One patient (no.12) had an abnormally high number of circulating B1 cells although his other results, including his S-antibody levels were normal. In the patient group as a whole the number of B-cells determined either as B1 positive or as surface immu noglobulin positive cells was no different com pared with the controls. T-helper CD4.
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Response to S-antigen
Serum antibody
The serum levels of S-antibody in patients and controls are expressed in Figure l (a) as the percentage binding to S-antigen compared with a positive reference serum. Both the patient and control groups showed a wide range of antibody levels with median levels not significantly different (patients: 68%, con trols: 101 %). The levels in patients were not related to disease severity, or to associated disease, nor did they correlate with any lym phocyte subpopulation, (data not shown).
S-antibody in Supernatants of pokeweed mitogen stimulated cultures
The levels of S-antibody in the supernatants were between one and 7% of the reference serum with no difference between patient and control results (median levels: patients 3. 2%, controls 3.6%). There was no correlation between S-antibody levels in PWM superna tants and serum.
Proliferative Response to S-antigen
The results are shown in Figure l(b) . The responses were predominantly negative for both patients and controls although three patients and one control had an elevated response. The proliferative response did not correlate with S-antibody levels either in serum or in the supernatants of PWM cul tures. The three patients (nos. 11, 12 and 14) with the raised response were not remarkable in any other way. Their lymphocyte sub population levels were normal and they had a positive response in both mitogens and antigens. 
Discussion
In this study we wished to confirm the lympho cyte abnormalities reported by other authors in patients with chronic posterior uveitis, (refs [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] , and if present, to determine whether they were attributable to their uveitis or whether they were correlated with an associ ated clinical syndrome such as sarcoidosis or toxoplasmosis. Secondly we wished to estab lish whether the reported immune sensitivity to retinal S-antigen is specific to patients with eye disease. We were unable to show any overall differ ence in the immune status of patients com pared with controls. When the patient group was subdivided into categories of severity however, a subgroup of four patients with severe eye disease (defined as retinal vas culitis with or without macular oedema) had a significantly reduced response to the environ mental antigen SK-SD. One of these four and a second patient with mild (category 2) disease had generally an abnormally low response to both antigen and mitogen stimu lation. The number of circulating T-cells in these patients was normal suggesting a func tional defect in their cell mediated immune system. The reduced response to SK-SD anti gen could be due to the loss or impairment of specific memory cells. Alternatively, reduced antigen responsiveness could be due to func tional impairment of the T-cell receptor for antigens, although why the reduction is specific for SK-SD and does not extend to PPD is unclear. An alternative method of measuring T-cell activation, such as the measurement of soluble activation products: e.g. migration inhibition factor, or in vivo skin testing to a range of re-call antigens may clar ify this observed defect.
In the lymphocyte subset results there was no significant difference between the patient and control groups. One patient had a slight lymphopenia which was reflected in both the T-helper and T-suppressor subsets but her functional responses were normal. We were unable to confirm the observation of Nussenblatt et al.7 that uveitis is associated with a reduced number of circulating T-cells. In their study, they found that there was no difference in lymphocyte subsets between uveitis patients and controls overall. How ever, they noticed that when patients with active posterior uveitis were compared with controls, there was a reduction in the T-helperlsuppressor cell ratio. In the present study, all patients had active disease and they were compared with a similar number of healthy controls. The number of circulating T-helper cells was marginally reduced in all the patient groups but the reduction was not statistically significant and, apart from one individual, not clinically significant. The number of circulating T-suppressor cells was similar in patients and controls.
Wakefield et al. have reported a 76% inci dence of T-Iymphopenia in patients with untreated retinal vasculitis. 22 We found no correlation between lymphocyte total counts or subpopulations and retinal vasculitis. The one patient with T-Iymphopenia had associ ated sarcoidosis but no evidence of retinal vasculitis. We analysed the data further on the basis of associated disease. The patient group included two patients with associated sar coidosis and five patients with presumed ocular toxoplasmosis or presumed ocular his toplasmosis. As mentioned above, the patient with lymphopenia also had sarcoidosis. One patient with toxoplasmosis and one with pre sumed ocular toxoplasmosis had reduced transformation responses to both antigens and mitogens. The other three had normal results. Thus, there is no clear association with associated disease although associated disease may be linked to immune deficiency in individuals.
Immune sensitivity to S-antigen was deter mined for both B-cells and T-cells. Serum antibody levels in patients varied widely from 34--185% of a reference serum. However, the healthy control group, with no history or evi dence of eye disease, had essentially the same range of results (28-140%) (Fig.1a) . Similarly when B-cells were stimulated with pokeweed mitogen the range of levels of anti-S-antibody in the supernatants was similar for both patients and controls (Fig.1b) .
These findings confirm two recent studies indicating that humoral reactivity to retinal S-antigen is a 'natural' phenomenon and does not correlate with disease activity.14 , 15 T-cell sensitivity was determined by incubating peripheral blood lymphocytes with bovine S-antigen and measuring proliferation after 96 hours. Here, too, the spread of results was similar in the patient and control groups. Cel lular reactivity to retinal S-antigen in human uveitis has been reported by Nussenblatt et al. , 1 0, 23 particularly in association with bird shot retinochoroidopathy. 23 The present study fails to support this work. High doses of S-antigen have been shown recently to induce in vitro proliferation responses in T lympho cytes of uveitis patients but similar responses were seen in a significant percentage of healthy controls. 24 The lack of detectable difference between patient and control responses to S-antigen may in part be due to the relative insensitivity of current tests. In any circulating pool of lymphocytes, only a very small proportion of cells will be sensitised to a specific antigen, particularly if the antigen is organ specific, is in relatively low con centration, and is normally excluded from the blood stream via physiological barriers such as the blood retinal barrier. Analysis of intra ocular fluids have also shown that there is considerable variation in the T-and B-cell counts but that in general the proportions of each cell type reflect those of the peripheral blood, and that such tests are equally likely to be unhelpful in the diagnosis or management of the disease.26 More recently, the presence of 'activated' T cells, bearing the interleukin 2 receptor, have been shown in uveitis patients27 and this may be of some relevance to disease activity.
In conclusion, our study suggests that there may be a functional deficiency in cell-medi ated immunity in patients with severe eye disease. As this study was carried out at a single time point for each patient we cannot say whether the abnormality is the cause or a result of the eye disease. We and others25 have been unable to confirm previous reports of reduced T-cells in eye disease5,7,22 probably because of the greater attention paid to the use of adequate control populations. Although individual patients have been shown to have very marked deficiencies in their cell-mediated immune system, we con clude that the extent of the functional differ ences is generally too small to be useful in the diagnosis and management of individual cases using current generally available methods of investigation.
